|
CWC15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.253170E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.268500E-02 |
| Normal-vs-Stage2 |
1.575800E-01 |
| Normal-vs-Stage3 |
5.528400E-01 |
| Normal-vs-Stage4 |
1.404430E-01 |
| Stage1-vs-Stage2 |
6.350200E-01 |
| Stage1-vs-Stage3 |
5.650000E-01 |
| Stage1-vs-Stage4 |
3.591600E-01 |
| Stage2-vs-Stage3 |
4.800200E-01 |
| Stage2-vs-Stage4 |
6.666600E-01 |
| Stage3-vs-Stage4 |
3.262800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.072800E-01 |
| Normal-vs-AfricanAmerican |
3.739800E-02 |
| Normal-vs-Asian |
4.474200E-01 |
| Caucasian-vs-AfricanAmerican |
1.422430E-01 |
| Caucasian-vs-Asian |
4.274000E-01 |
| AfricanAmerican-vs-Asian |
8.226000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.198600E-01 |
| Normal-vs-Female |
9.515500E-03 |
| Male-vs-Female |
1.625760E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.795870E-02 |
| Normal-vs-Extreme_Weight |
2.088200E-01 |
| Normal-vs-Obese |
1.281830E-01 |
| Normal-vs-Extreme_Obese |
7.562000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.018570E-01 |
| Normal_Weight-vs-Obese |
2.129200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.109400E-01 |
| Extreme_Weight-vs-Obese |
7.100000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.357600E-01 |
| Obese-vs-Extreme_Obese |
8.458200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.618900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.224100E-02 |
| Normal-vs-Age(61-80Yrs) |
6.539200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.517600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.587200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.051600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.745800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.302500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.661200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.143500E-02 |
| Normal-VS-Type2 PRCC |
8.327200E-01 |
| Normal-VS-KIRP CIMP |
1.075430E-01 |
| Normal-VS-Unclassified PRCC |
7.100800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.528790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.206400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.489800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.889800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.651400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.100800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.274600E-01 |
| Normal-vs-N1 |
2.817800E-01 |
| Normal-vs-N2 |
6.357800E-01 |
| N0-vs-N1 |
7.159800E-01 |
| N0-vs-N2 |
2.882000E-01 |
| N1-vs-N2 |
2.852800E-01 |
|
|
